HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].

AbstractOBJECTIVE:
To investigate the clinical features of multiple myeloma (MM) complicated by extramedullary plasmacytomas (EM).
METHODS:
Twenty five patients were enrolled into the study. The proportion male to female was 15:10 and the median age 55.2 years. The distribution of different isotypes was IgA ten, IgG nine and light chain lambda five. The sites of complicating plasmacytoma included muscle, bone, skin, rectum, and testicles. The most common site was muscle.
RESULTS:
Patients with complicated extramedullary plasmacytomas at the time of diagnosis received traditional treatment, including vincristine adriamycin, dexamethasone, medphalan, prednisone, thalidomide and bortezomib. Rates of overall response (ORR) were 80%. Plasmacytomas occurring after the diagnosis of MM received cisplatin, etoposide, cyclophosphamide, prednisone, or bortezomib ORR were 66.7%, 50.0%.
CONCLUSION:
These results lend support to the efficacy of bortezomib in the treatment of plasmacytoma. MM cases with unconventional disease recurrence are likely to be seen due to sub-clinical seeding of tumour cells suggestive of the presence of an EM clone of plasma cells with a high degree of chemoresistance. Available data in the literature concerning the optimal therapy for patients with EM relapse were reviewed.
AuthorsYu-ping Zhong, Shi-lun Chen
JournalZhonghua nei ke za zhi (Zhonghua Nei Ke Za Zhi) Vol. 48 Issue 5 Pg. 396-8 (May 2009) ISSN: 0578-1426 [Print] China
PMID19615158 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Dexamethasone
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Boronic Acids (administration & dosage)
  • Bortezomib
  • Dexamethasone (administration & dosage)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma (complications, drug therapy, pathology)
  • Neoplasm Staging
  • Plasmacytoma (complications, drug therapy, pathology)
  • Prognosis
  • Pyrazines (administration & dosage)
  • Thalidomide (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: